Mutations in PPARγ lead to dysfunctional lipid and glucose homeostasis and have been directly related to type 2 diabetes mellitus and obesity [13], familial partial lipodystrophy type 3 (FPLD3) [14], and also cancer [15,16]. The gene discussed is PPARG; the disease is PPARG-related familial partial lipodystrophy.